Medpace Holdings, Inc. (FRA:01P)

Germany · Delayed Price · Currency is EUR

482.70

+0.40 (0.08%)

Last updated: Dec 22, 2025, 8:10 AM CET

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
Oncology Revenue	719.84M	651.24M	Log In	Log In	Log In	Upgrade
Metabolic Revenue	618.01M	457.54M	Log In	Log In	Log In	Upgrade
Other Sources of Revenue	423.48M	431.38M	Log In	Log In	Log In	Upgrade
Cardiology Revenue	234.64M	230.45M	Log In	Log In	Log In	Upgrade
Central Nervous System Revenue	230.88M	181.98M	Log In	Log In	Log In	Upgrade
AVAI Revenue	131.53M	156.46M	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.36B	2.11B	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
Net New Business Awards	2.44B	2.23B	Log In	Log In	Log In	Upgrade
Total Backlog	3.00B	2.90B	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.